http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2889916-T3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3166d2820b5872ab84d235e5fae1d45
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-333
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-402
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-333
filingDate 2014-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51114dff67f16535b10fcdc6c6ce2447
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a52a9dd6488bd30ba3890c2aef0045b5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_baceec7ae14d9827d6f78eb82209a445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_607b198a00df316ed366a398c7ea508c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b2abbb000aef9cea97e52b1a063480f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d59d8ce2f47bd21a6a9953559f53a636
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_571949ec82ad8e3ceb20b4f4896c3070
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7fecee4e1725baf3eea6c993f34248a6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40c838a694c1e2eeba5532643b555ecd
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_77918e1639ae4c4d7baa146e6af7c424
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6baa3627614e6f034fab68034c532010
publicationDate 2022-01-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber ES-2889916-T3
titleOfInvention A procedure for the preparation of pyrroles with hypolipidemic and hypocholesteremic activities
abstract A method of preparing magnesium saroglitazar of Formula (I), **(See formula)** comprising the method: (a) reacting a hydroxy compound (A) with a mesylate compound (A1) in a mixture of organic solvents in the presence of a base and a phase transfer catalyst at a temperature of 35°C to 85°C to obtain an alkoxy ester compound of Formula (II); **(See formula)** (b) hydrolyzing the alkoxy ester compound of Formula (II) with a base to obtain saroglitazar; and (c) reacting saroglitazar with a magnesium source to obtain saroglitazar magnesium of Formula (I); wherein the organic solvent mixture comprises cyclohexane and one or more of alcohols selected from methanol, ethanol, isopropanol, 2-propanol, 1-butanol, and t-butyl alcohol; ketones selected from acetone, butanone, and methyl isobutyl ketone; esters selected from ethyl acetate, isopropyl acetate, t-butyl acetate, and isobutyl acetate; chlorinated hydrocarbons selected from methylene dichloride, ethylene dichloride, and chlorobenzene; hydrocarbons selected from pentane, hexane and heptane and ethers selected from tetrahydrofuran, 1,4-dioxane, diisopropyl ether, diethyl ether and methyl tert-butyl ether.
priorityDate 2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID117944570
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414109481
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID416068811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466180782
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID725701
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468286677
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466180774

Total number of triples: 35.